corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 2031

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Drug-company decision to end cancer trial.
Lancet 1999 Sep 25; 354:(9184):1045
http://linkinghub.elsevier.com/retrieve/pii/S0140673699003207

Keywords:
Publication Types: Editorial MeSH Terms: Advisory Committees Antidotes/therapeutic use Antimetabolites, Antineoplastic/adverse effects* Clinical Trials Colonic Neoplasms/drug therapy* Control Groups Drug Industry Europe Fluorouracil/therapeutic use Humans Leucovorin/therapeutic use Multicenter Studies Quinazolines/adverse effects* Research Subjects Thiophenes/adverse effects* Substances: Antidotes Antimetabolites, Antineoplastic Quinazolines Thiophenes raltitrexed Fluorouracil Leucovorin

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend